Official registry condition

Sepsis peptide trials

5 selected ClinicalTrials.gov records carrying the official condition label Sepsis. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

5 selected records.

Connected peptides

3 profiles.

Registry update years

2013–2026 in selected records.

Indication intelligence

Selected evidence landscape

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses3

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 90 selected PubMed records and 46 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Sepsis unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00942149

PeptideScanner retained ClinicalTrials.gov record NCT00942149 at 2026-11-15T22:01:45.056Z. Its registry update date was 2013-07-15, and PeptideScanner's reviewed identity mapping was daptomycin.

PeptideScanner change date
November 15, 2026
Cited source date
July 15, 2013
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02867267

PeptideScanner retained ClinicalTrials.gov record NCT02867267 at 2026-11-15T22:10:40.222Z. Its registry update date was 2023-04-10, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 10, 2023
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT02883595

PeptideScanner retained ClinicalTrials.gov record NCT02883595 at 2026-11-15T22:10:40.222Z. Its registry update date was 2019-04-04, and PeptideScanner's reviewed identity mapping was thymosin-alpha-1.

PeptideScanner change date
November 15, 2026
Cited source date
April 4, 2019
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →